Results from Phase 1b Studies for C3 Inhibitor

Posted on July 12, 2018

This is the sub cutaneous daily injection which inhibits the C3 part of the complement system (rather than C5) and is promising for those who still need blood transfusions whilst […]

Phase 1 Trial starts for Achillion’s Oral Therapy

Posted on July 12, 2018

“Achillion Pharmaceuticals, Inc. announced (10 July) that the Company had begun dosing healthy volunteer subjects in a first-in-human phase 1 trial of ACH-5548, an oral small-molecule complement factor D inhibitor. ACH-5548 […]

Archives By Month: July 2018

Results from Phase 1b Studies for C3 Inhibitor

Phase 1 Trial starts for Achillion’s Oral Therapy

How do I keep emotionally healthy?

COURSE (short) Managing Stress and Uncertainty with Maria Mullan

Mindfulness for Stress Taster Session

COURSE Managing Stress and Living with Uncertainty with Catarina Baptista

PNH Patient/Family Online Meeting – Saturday 17 May 2025 – 10.30am to 12pm